Skip to main content
Erschienen in: World Journal of Surgery 11/2011

01.11.2011

Staging of Peripheral-Type Intrahepatic Cholangiocarcinoma: Appraisal of the New TNM Classification and its Modifications

verfasst von: Tsuyoshi Igami, Tomoki Ebata, Yukihiro Yokoyama, Gen Sugawara, Yu Takahashi, Masato Nagino

Erschienen in: World Journal of Surgery | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

In the seventh edition, the TNM classification for intrahepatic cholangiocarcinoma (IHC) is separated from that for hepatocellular carcinoma. Because it is the first independent classification for IHC, the validity of the new classification needs to be evaluated.

Methods

The medical records of 93 patients with peripheral-type IHC who underwent treatment (61 resected and 32 unresectable tumors) were retrospectively reviewed focusing on the new TNM classification for IHC.

Results

The 5-year survival rate and the median survival time for the 61 patients with resected tumors were 33.9% and 2.05 years, respectively. The survival of the patients with periductal invasion was similar to that of the patients without. The survival of the patients with metastasis to the gastrohepatic lymph nodes (G-LN) was dismal without any 2-year survivors and similar to that of the patients with unresectable tumors (P = 0.247). On multivariate analysis, histologic differentiation (P = 0.034), multiple tumors (P = 0.014), lymph node metastasis (P < 0.001), and distant metastasis other than lymph node metastasis (P = 0.007) were identified as independent prognostic factors. According to the above results, we modified the new TNM classification as follows: IHC with multiple tumors was classified as pT4 disease; periductal invasion was excluded from determinant of the T-categories; and metastasis to G-LN was treated as distant metastasis. The survival curves based on our modifications were better stratified than those based on the new TNM classification.

Conclusions

The TNM classification for IHC included some clinical inconsistencies; therefore, we proposed some modifications of the new TNM classification for IHC and demonstrated that these modifications offer better stratification of the survival data. Further revisions are necessary for its improvement.
Literatur
1.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC et al (eds) (2009) AJCC cancer staging manual, 7th edn. Springer, New York Edge SB, Byrd DR, Compton CC et al (eds) (2009) AJCC cancer staging manual, 7th edn. Springer, New York
2.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2009) International Union Against Cancer (UICC). TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Oxford Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2009) International Union Against Cancer (UICC). TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Oxford
3.
Zurück zum Zitat Nakeeb A, Pitt HA, Sohn TA et al (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224:463–473PubMedCrossRef Nakeeb A, Pitt HA, Sohn TA et al (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224:463–473PubMedCrossRef
4.
Zurück zum Zitat Ebata T, Kamiya J, Nishio H et al (2009) The concept of perihilar cholangiocarcinoma. Br J Surg 96:926–934PubMedCrossRef Ebata T, Kamiya J, Nishio H et al (2009) The concept of perihilar cholangiocarcinoma. Br J Surg 96:926–934PubMedCrossRef
5.
Zurück zum Zitat Nimura Y, Hayakawa N, Kamiya J et al (1991) Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg 78:727–731PubMedCrossRef Nimura Y, Hayakawa N, Kamiya J et al (1991) Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg 78:727–731PubMedCrossRef
6.
Zurück zum Zitat Ebata T, Nagino M, Kamiya J et al (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238:720–727PubMedCrossRef Ebata T, Nagino M, Kamiya J et al (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238:720–727PubMedCrossRef
7.
Zurück zum Zitat Miyazaki M, Kato A, Ito H et al (2007) Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141:581–588PubMedCrossRef Miyazaki M, Kato A, Ito H et al (2007) Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141:581–588PubMedCrossRef
8.
Zurück zum Zitat Nagino M, Yamada T, Kamiya J et al (2003) Left hepatic trisegmentectomy with right hepatic vein resection after right hepatic vein embolization. Surgery 133:580–582PubMedCrossRef Nagino M, Yamada T, Kamiya J et al (2003) Left hepatic trisegmentectomy with right hepatic vein resection after right hepatic vein embolization. Surgery 133:580–582PubMedCrossRef
9.
Zurück zum Zitat Nagino M, Nimura Y, Nishio H et al (2010) Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg 252:115–123PubMedCrossRef Nagino M, Nimura Y, Nishio H et al (2010) Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg 252:115–123PubMedCrossRef
10.
Zurück zum Zitat Nozaki Y, Yamamoto M, Ikai I et al (1998) Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma. Cancer 83:1923–1929PubMedCrossRef Nozaki Y, Yamamoto M, Ikai I et al (1998) Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma. Cancer 83:1923–1929PubMedCrossRef
11.
Zurück zum Zitat Okabayashi T, Yamamoto J, Kosuge T et al (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92:2374–2383PubMedCrossRef Okabayashi T, Yamamoto J, Kosuge T et al (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92:2374–2383PubMedCrossRef
12.
Zurück zum Zitat Yamasaki S (2003) Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10:288–291PubMedCrossRef Yamasaki S (2003) Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10:288–291PubMedCrossRef
13.
Zurück zum Zitat Nathan H, Aloia TA, Vauthey JN et al (2009) A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16:14–22PubMedCrossRef Nathan H, Aloia TA, Vauthey JN et al (2009) A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16:14–22PubMedCrossRef
14.
Zurück zum Zitat Jonas S, Thelen A, Benckert C et al (2009) Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg 249:303–309PubMedCrossRef Jonas S, Thelen A, Benckert C et al (2009) Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg 249:303–309PubMedCrossRef
15.
Zurück zum Zitat Uenishi T, Kubo S, Yamazaki O et al (2008) Indication for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 15:417–422PubMedCrossRef Uenishi T, Kubo S, Yamazaki O et al (2008) Indication for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 15:417–422PubMedCrossRef
17.
Zurück zum Zitat Hirohashi K, Uenishi T, Kubo S et al (2002) Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 49:326–329PubMed Hirohashi K, Uenishi T, Kubo S et al (2002) Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 49:326–329PubMed
18.
20.
Zurück zum Zitat Ohtsuka M, Ito H, Kimura F et al (2002) Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89:1525–1531PubMedCrossRef Ohtsuka M, Ito H, Kimura F et al (2002) Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89:1525–1531PubMedCrossRef
21.
Zurück zum Zitat Endo I, Gonen M, Yopp AC et al (2008) Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248:84–96PubMedCrossRef Endo I, Gonen M, Yopp AC et al (2008) Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248:84–96PubMedCrossRef
22.
Zurück zum Zitat Shimada K, Sano T, Nara S et al (2009) Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery 145:411–416PubMedCrossRef Shimada K, Sano T, Nara S et al (2009) Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery 145:411–416PubMedCrossRef
23.
Zurück zum Zitat Paik KY, Jung JC, Heo JS et al (2008) What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 23:766–770PubMedCrossRef Paik KY, Jung JC, Heo JS et al (2008) What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 23:766–770PubMedCrossRef
24.
Zurück zum Zitat Tamandl D, Herberger B, Gruenberger B et al (2008) Influence of hepatic margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 15:2787–2794PubMedCrossRef Tamandl D, Herberger B, Gruenberger B et al (2008) Influence of hepatic margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 15:2787–2794PubMedCrossRef
25.
Zurück zum Zitat Valverde A, Bonhomme N, Farges O et al (1999) Resection of intrahepatic cholangiocarcinoma: a western experience. J Hepatobiliary Pancreat Surg 2:122–127CrossRef Valverde A, Bonhomme N, Farges O et al (1999) Resection of intrahepatic cholangiocarcinoma: a western experience. J Hepatobiliary Pancreat Surg 2:122–127CrossRef
27.
Zurück zum Zitat Tamandl D, Kaczirek K, Gruenberger B et al (2009) Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg 96:919–925PubMedCrossRef Tamandl D, Kaczirek K, Gruenberger B et al (2009) Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg 96:919–925PubMedCrossRef
28.
Zurück zum Zitat Uenishi T, Yamazaki O, Yamamoto T et al (2005) Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 12:479–483PubMedCrossRef Uenishi T, Yamazaki O, Yamamoto T et al (2005) Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 12:479–483PubMedCrossRef
29.
Zurück zum Zitat Choi SB, Kim KS, Choi JY et al (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16:3048–3056PubMedCrossRef Choi SB, Kim KS, Choi JY et al (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16:3048–3056PubMedCrossRef
30.
Zurück zum Zitat Shimada M, Yamashita Y, Aishima S et al (2001) Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88:1463–1466PubMedCrossRef Shimada M, Yamashita Y, Aishima S et al (2001) Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88:1463–1466PubMedCrossRef
31.
Zurück zum Zitat Tsuji T, Hiraoka T, Kanemitsu K et al (2001) Lymphatic spreading pattern of intrahepatic cholangiocarcinoma. Surgery 129:401–407PubMed Tsuji T, Hiraoka T, Kanemitsu K et al (2001) Lymphatic spreading pattern of intrahepatic cholangiocarcinoma. Surgery 129:401–407PubMed
32.
Zurück zum Zitat Yedibela S, Demir R, Zhang W et al (2009) Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year western single-center experience in 107 patients. Ann Surg Oncol 16:404–412PubMedCrossRef Yedibela S, Demir R, Zhang W et al (2009) Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year western single-center experience in 107 patients. Ann Surg Oncol 16:404–412PubMedCrossRef
33.
Zurück zum Zitat Kawarada Y, Yamagiwa K, Das BC (2002) Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 183:679–685PubMedCrossRef Kawarada Y, Yamagiwa K, Das BC (2002) Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 183:679–685PubMedCrossRef
34.
Zurück zum Zitat Inoue K, Makuuchi M, Takayama T et al (2000) Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 127:498–505PubMedCrossRef Inoue K, Makuuchi M, Takayama T et al (2000) Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 127:498–505PubMedCrossRef
35.
Zurück zum Zitat Shirabe K, Shimada M, Harimoto N et al (2002) Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 131:S159–S164PubMedCrossRef Shirabe K, Shimada M, Harimoto N et al (2002) Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 131:S159–S164PubMedCrossRef
Metadaten
Titel
Staging of Peripheral-Type Intrahepatic Cholangiocarcinoma: Appraisal of the New TNM Classification and its Modifications
verfasst von
Tsuyoshi Igami
Tomoki Ebata
Yukihiro Yokoyama
Gen Sugawara
Yu Takahashi
Masato Nagino
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 11/2011
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1242-0

Weitere Artikel der Ausgabe 11/2011

World Journal of Surgery 11/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.